articleTop 1% cited
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
American Journal of Psychiatry · 2006 · Vol. 163(1) · pp. 28–40
Madhukar H. Trivedi✉(The University of Texas Southwestern Medical Center)A. John RushStephen R. WisniewskiAndrew A. NierenbergDiane WardenLouise RitzGrayson NorquistRobert H. HowlandBarry D. LebowitzPatrick J. McGrathKathy Shores‐WilsonMelanie M. BiggsG.K. BalasubramaniMaurizio FavaSTAR*D Study Team
Abstract
The response and remission rates in this highly generalizable sample with substantial axis I and axis III comorbidity closely resemble those seen in 8-week efficacy trials. The systematic use of easily implemented measurement-based care procedures may have assisted in achieving these results.
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSchizophrenia research and treatmentCitalopramDepression (economics)Major depressive disorderMedicineRating scalePrimary careMajor depressive episodePsychiatrySerotonin reuptake inhibitorInternal medicine
MeSH terms
AdolescentAmbulatory CareMental DisordersChronic DiseaseMajor Depressive DisorderDepressive Disorder, MajorDose-Response Relationship, DrugDrug Administration ScheduleFemaleHumansMaleMiddle AgedPersonality InventoryPsychiatric Status Rating ScalesCitalopram
Citations
3,835
FWCI
133.33
field-weighted impact
References
71
Percentile
100%
vs. same field & year
Citations per year
Cited by
A Tipping Point for Measurement-Based Care
Psychiatric Services · 2016 · 540 citations
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Biological Psychiatry · 2011 · 1,074 citations
Glutamate receptor ion channels
Current Opinion in Neurobiology · 2005 · 3,657 citations
Signaling pathways underlying the rapid antidepressant actions of ketamine
Neuropharmacology · 2011 · 528 citations
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Neuropsychopharmacology · 2006 · 688 citations
Towards a glutamate hypothesis of depression
Neuropharmacology · 2011 · 1,005 citations
Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
Frontiers in Neuroscience · 2018 · 349 citations
Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment
Drugs · 2015 · 445 citations
References
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
Biological Psychiatry · 2003 · 3,812 citations
The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations.
Journal of Personality and Social Psychology · 1986 · 71,935 citations
CUMULATIVE ILLNESS RATING SCALE
Journal of the American Geriatrics Society · 1968 · 2,299 citations
The Work and Social Adjustment Scale: a simple measure of impairment in functioning
The British Journal of Psychiatry · 2002 · 2,508 citations
A RATING SCALE FOR DEPRESSION
Journal of Neurology Neurosurgery & Psychiatry · 1960 · 32,326 citations
Mediators and Moderators of Treatment Effects in Randomized Clinical Trials
Archives of General Psychiatry · 2002 · 2,561 citations
The Epidemiology of Major Depressive Disorder
JAMA · 2003 · 7,949 citations
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
Psychological Medicine · 2004 · 981 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.